73.34 USD
+0.46 (+0.63%)
73.34 USD
0 (0%)
HSIC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. HSIC has a medium profitability rating, but doesn't score so well on its financial health evaluation. HSIC has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
HSIC had positive earnings in the past year.
HSIC had a positive operating cash flow in the past year.
Each year in the past 5 years HSIC has been profitable.
Each year in the past 5 years HSIC had a positive operating cash flow.
1.2 Ratios
HSIC has a Return On Assets of 3.52%. This is in the better half of the industry: HSIC outperforms 67.33% of its industry peers.
HSIC has a better Return On Equity (11.63%) than 77.23% of its industry peers.
With a decent Return On Invested Capital value of 6.64%, HSIC is doing good in the industry, outperforming 66.34% of the companies in the same industry.
HSIC had an Average Return On Invested Capital over the past 3 years of 8.02%. This is in line with the industry average of 9.22%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.52% | ||
| ROE | 11.63% | ||
| ROIC | 6.64% |
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
1.3 Margins
With a decent Profit Margin value of 3.02%, HSIC is doing good in the industry, outperforming 67.33% of the companies in the same industry.
HSIC's Profit Margin has declined in the last couple of years.
HSIC's Operating Margin of 5.94% is fine compared to the rest of the industry. HSIC outperforms 63.37% of its industry peers.
HSIC's Operating Margin has declined in the last couple of years.
HSIC has a Gross Margin of 31.19%. This is comparable to the rest of the industry: HSIC outperforms 57.43% of its industry peers.
HSIC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.94% | ||
| PM (TTM) | 3.02% | ||
| GM | 31.19% |
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HSIC is destroying value.
Compared to 1 year ago, HSIC has less shares outstanding
HSIC has less shares outstanding than it did 5 years ago.
The debt/assets ratio for HSIC is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.62 indicates that HSIC is not a great score, but indicates only limited risk for bankruptcy at the moment.
HSIC has a Altman-Z score of 2.62. This is comparable to the rest of the industry: HSIC outperforms 56.44% of its industry peers.
The Debt to FCF ratio of HSIC is 8.70, which is on the high side as it means it would take HSIC, 8.70 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 8.70, HSIC perfoms like the industry average, outperforming 50.49% of the companies in the same industry.
A Debt/Equity ratio of 0.91 indicates that HSIC is somewhat dependend on debt financing.
HSIC has a Debt to Equity ratio of 0.91. This is comparable to the rest of the industry: HSIC outperforms 41.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 8.7 | ||
| Altman-Z | 2.62 |
ROIC/WACC0.79
WACC8.45%
2.3 Liquidity
HSIC has a Current Ratio of 1.40. This is a normal value and indicates that HSIC is financially healthy and should not expect problems in meeting its short term obligations.
HSIC has a Current ratio of 1.40. This is comparable to the rest of the industry: HSIC outperforms 51.49% of its industry peers.
HSIC has a Quick Ratio of 1.40. This is a bad value and indicates that HSIC is not financially healthy enough and could expect problems in meeting its short term obligations.
HSIC has a Quick ratio of 0.79. This is in the lower half of the industry: HSIC underperforms 76.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.49% over the past year.
Measured over the past 5 years, HSIC shows a small growth in Earnings Per Share. The EPS has been growing by 6.19% on average per year.
The Revenue has been growing slightly by 3.51% in the past year.
The Revenue has been growing slightly by 4.88% on average over the past years.
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%
3.2 Future
HSIC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.14% yearly.
The Revenue is expected to grow by 3.28% on average over the next years.
EPS Next Y3.76%
EPS Next 2Y5.94%
EPS Next 3Y7.19%
EPS Next 5Y8.14%
Revenue Next Year1.74%
Revenue Next 2Y2.59%
Revenue Next 3Y2.89%
Revenue Next 5Y3.28%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 15.22 indicates a correct valuation of HSIC.
Compared to the rest of the industry, the Price/Earnings ratio of HSIC indicates a rather cheap valuation: HSIC is cheaper than 83.17% of the companies listed in the same industry.
HSIC is valuated rather cheaply when we compare the Price/Earnings ratio to 26.41, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 13.79 indicates a correct valuation of HSIC.
Based on the Price/Forward Earnings ratio, HSIC is valued cheaper than 81.19% of the companies in the same industry.
HSIC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.22 | ||
| Fwd PE | 13.79 |
4.2 Price Multiples
HSIC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HSIC is cheaper than 73.27% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HSIC is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.25 | ||
| EV/EBITDA | 9.94 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HSIC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.04
PEG (5Y)2.46
EPS Next 2Y5.94%
EPS Next 3Y7.19%
5. Dividend
5.1 Amount
No dividends for HSIC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
73.34
+0.46 (+0.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners99.98%
Inst Owner Change-5%
Ins Owners0.77%
Ins Owner Change-0.09%
Market Cap8.63B
Revenue(TTM)12.94B
Net Income(TTM)391.00M
Analysts69.57
Price Target78.71 (7.32%)
Short Float %7.05%
Short Ratio4.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.88%
Min EPS beat(2)-9.54%
Max EPS beat(2)5.78%
EPS beat(4)2
Avg EPS beat(4)-1.38%
Min EPS beat(4)-9.54%
Max EPS beat(4)5.78%
EPS beat(8)4
Avg EPS beat(8)-0.56%
EPS beat(12)5
Avg EPS beat(12)-0.94%
EPS beat(16)7
Avg EPS beat(16)0.24%
Revenue beat(2)0
Avg Revenue beat(2)-0.76%
Min Revenue beat(2)-1.43%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-2.59%
Min Revenue beat(4)-5.06%
Max Revenue beat(4)-0.09%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)0
Avg Revenue beat(12)-3.01%
Revenue beat(16)1
Avg Revenue beat(16)-2.68%
PT rev (1m)5.05%
PT rev (3m)6.5%
EPS NQ rev (1m)0.06%
EPS NQ rev (3m)-0.35%
EPS NY rev (1m)0.01%
EPS NY rev (3m)-0.06%
Revenue NQ rev (1m)0.56%
Revenue NQ rev (3m)0.68%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.22 | ||
| Fwd PE | 13.79 | ||
| P/S | 0.67 | ||
| P/FCF | 24.25 | ||
| P/OCF | 16.14 | ||
| P/B | 2.57 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.94 |
EPS(TTM)4.82
EY6.57%
EPS(NY)5.32
Fwd EY7.25%
FCF(TTM)3.02
FCFY4.12%
OCF(TTM)4.54
OCFY6.2%
SpS109.9
BVpS28.55
TBVpS-15.56
PEG (NY)4.04
PEG (5Y)2.46
Graham Number55.64
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.52% | ||
| ROE | 11.63% | ||
| ROCE | 9.68% | ||
| ROIC | 6.64% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 16.65% | ||
| OM | 5.94% | ||
| PM (TTM) | 3.02% | ||
| GM | 31.19% | ||
| FCFM | 2.75% |
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
ROICexc(3y)8.17%
ROICexc(5y)8.74%
ROICexgc(3y)19.66%
ROICexgc(5y)20.9%
ROCE(3y)10.93%
ROCE(5y)11.41%
ROICexgc growth 3Y-9.94%
ROICexgc growth 5Y-7.93%
ROICexc growth 3Y-12.98%
ROICexc growth 5Y-8.63%
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
F-Score5
Asset Turnover1.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 8.7 | ||
| Debt/EBITDA | 2.85 | ||
| Cap/Depr | 58.69% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 5.16 | ||
| Cash Conversion | 49.81% | ||
| Profit Quality | 91.05% | ||
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2.62 |
F-Score5
WACC8.45%
ROIC/WACC0.79
Cap/Depr(3y)61.22%
Cap/Depr(5y)49.53%
Cap/Sales(3y)1.25%
Cap/Sales(5y)0.97%
Profit Quality(3y)112.93%
Profit Quality(5y)114.98%
High Growth Momentum
Growth
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
EPS Next Y3.76%
EPS Next 2Y5.94%
EPS Next 3Y7.19%
EPS Next 5Y8.14%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%
Revenue Next Year1.74%
Revenue Next 2Y2.59%
Revenue Next 3Y2.89%
Revenue Next 5Y3.28%
EBIT growth 1Y26.48%
EBIT growth 3Y-5.01%
EBIT growth 5Y0.11%
EBIT Next Year14.87%
EBIT Next 3Y8.36%
EBIT Next 5Y7.01%
FCF growth 1Y-45.15%
FCF growth 3Y1.58%
FCF growth 5Y1.99%
OCF growth 1Y-31.93%
OCF growth 3Y6.12%
OCF growth 5Y4.66%
HENRY SCHEIN INC / HSIC FAQ
Can you provide the ChartMill fundamental rating for HENRY SCHEIN INC?
ChartMill assigns a fundamental rating of 4 / 10 to HSIC.
Can you provide the valuation status for HENRY SCHEIN INC?
ChartMill assigns a valuation rating of 5 / 10 to HENRY SCHEIN INC (HSIC). This can be considered as Fairly Valued.
Can you provide the profitability details for HENRY SCHEIN INC?
HENRY SCHEIN INC (HSIC) has a profitability rating of 6 / 10.
What is the earnings growth outlook for HENRY SCHEIN INC?
The Earnings per Share (EPS) of HENRY SCHEIN INC (HSIC) is expected to grow by 3.76% in the next year.